compounding semaglutide enforcement news FDA free to pursue compounders after latest court ruling FDA sets tirzepatide compounding deadlines

Hair Loss with GLP-1 Medication: Understanding and Preventing Telogen Effluvium GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) have revolutionized weight loss and metabolic health

Tirzepatide mimics the effects of GLP-1 and GIP, enhancing insulin secretion, lowering glucagon levels, and slowing gastric emptying, which reduces appetite and increases feelings of fullness

This does not mean retatrutide is simply a fat burner

(10) W Larbig, W D Gerber, M Kluck, and G A Schoenenberger (1984) Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes